California Cancer Reporting System Standards, Volume III
Eureka Edits
IF536: CS SSF 3, MyelomaPlasmaCellDisorder (CS)
Edit Sets:
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
Fields:
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
CS Site-Specific Factor 3 [NAACCR #2900]
CS Site-Specific Factor25 [NAACCR #2879]
Message:
IF 536: Conflict among schema and CS Site-Specific Factor 3 (value)
Specification:
The purpose of this edit is to verify that CS Site-Specific Factor 3 (Multiple Myeloma Terminology is coded properly for the MyelomaPlasmaCellDisorder schema. The schema includes histologies 9731, 9732, and 9734, but some of the CS Site-Specific Factor 3 values apply only to a subset of the three histologies.
This edit is skipped if any of the following conditions are true:
Site-Specific Factor 3 is empty
CS schema is invalid
This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.
If schema is MyelomaPlasmaCellDisorder:
1. The following CS Site-Specific Factor 3 codes are allowed only for 9732 >
000 Multiple myeloma/Plasma cell myeloma with no other modifiers
010 Asymptomatic myeloma
020 Early or evolving myeloma
030 Inactive, indolent, or smoldering myeloma
080 Other terminology describing myeloma
100 Any combination of terms in codes 010-080
999 Unknown
2. The following CS Site-Specific Factor 3 code is allowed only for 9731 (Plasmacytoma, NOS) and 9734 (Plasmacytoma, extramedullary):
987 Not applicable
Historical Changes:
In the SEER*Edits software, the title of this edit is: IF344.
2011 Data Item Changes: New edit - added to NAACCR v12.1 metafile.
04/2014 Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll."